← All organizations

Biosplice Therapeutics

For profitWebsite ↗

Also known as: Biosplice Therapeutics, Inc. | Samumed LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2025

Timeline

2000s

Jun 1, 2008
Biosplice Therapeutics— Founded

Drugs by trial phase (13 distinct, 23 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (42)

NCT07155200CollaboratorPhase 1/Phase 2Dec 31, 2025
NCT07032285CollaboratorPhase 2Jan 15, 2025
NCT05603754Study directorPhase 3Nov 18, 2022
NCT05603754Lead sponsorPhase 3Nov 18, 2022
NCT05084859Lead sponsorPhase 1Nov 3, 2021
NCT05084859Study chairPhase 1Nov 3, 2021
NCT04931667Lead sponsorPhase 3Jul 15, 2021
NCT04931667Study directorPhase 3Jul 15, 2021
NCT04598542Study directorPhase 1Oct 13, 2020
NCT04598542Lead sponsorPhase 1Oct 13, 2020
NCT04520607Study directorPhase 3Aug 25, 2020
NCT04520607Lead sponsorPhase 3Aug 25, 2020
NCT04385303Study directorPhase 3May 31, 2020
NCT04385303Lead sponsorPhase 3May 31, 2020
NCT03928184Lead sponsorPhase 3May 17, 2019

Details

Founded: San Diego, CA, US Jun 1, 2008
Last known activity: Dec 31, 2025

Notes

formerly Samumed LLC